NCT06634394
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06634394
Title APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aptevo Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute RECRUITING Denver Colorado 80218 United States Details
University of Miami RECRUITING Miami Florida 33124 United States Details
University of Kansas RECRUITING Fairway Kansas 66205 United States Details
Gabrail Cancer Center RECRUITING Canton Ohio 44718 United States Details
Oncology Hematology Care RECRUITING Cincinnati Ohio 45226 United States Details
University of Texas Southwestern Medical Center RECRUITING Dallas Texas 75390 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field